LONGFELLOW INVESTMENT MANAGEMENT CO LLC
Position in VRXA — Veraxa Biotech AG - Post de-SPAC
CIK 1167487
BOSTON, MA
Position in VRXA
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$0
New position
Shares Held
194
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026LONGFELLOW INVESTMENT MANAGEMENT CO LLC holds $82,537 across 3 Biotechnology names. VRXA ranks #3 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | 611 | $81,098 | |||
| 2 | RNA |
Atrium Therapeutics, Inc.
|
107 | $1,439 | |
| 3 | VRXA |
Veraxa Biotech AG - Post de-SPAC
This page
|
194 | $0 |
No Holdings History
No holdings records found for this institution in VRXA.